Search results
Neonatal jaundice. Treatment threshold graphs. NICE clinical guideline 98. Developed by the National Collaborating Centre for Women’s and Children’s Health. These treatment threshold graphs accompany the clinical guideline: ‘Neonatal jaundice’. They are also available as an implementation tool.
5 sie 2022 · This clinical practice guideline provides specific recommendations where evidence or significant clinical experience suggests the benefit of the clinical action. In some cases, options for clinical care delivery are provided when the evidence or clinical experience is less certain.
19 maj 2010 · This guideline covers diagnosing and treating jaundice, which is caused by increased levels of bilirubin in the blood, in newborn babies (neonates). It aims to help detect or prevent very high levels of bilirubin, which can be harmful if not treated.
12 cze 2023 · Neonatal hyperbilirubinemia is the most commonly encountered clinical issue in newborn babies. A number of risk factors contribute to severe hyperbilirubinemia in newborn infants with gestational age ≥ 35 weeks.
Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.
12 kwi 2018 · The document outlines the physiology, causes as fetal red blood cell breakdown and liver immaturity, signs as yellow skin and sclera, and management which may include increased feeding or phototherapy to reduce high bilirubin levels. Neonatal jaundice - Download as a PDF or view online for free.
18 maj 2010 · This document discusses neonatal jaundice (hyperbilirubinemia) in newborns. It defines jaundice as an excessive level of bilirubin in the blood seen as yellowing of the skin. It distinguishes between physiological and pathological jaundice.
